[胰岛素治疗技术的发展史]
P A Kazaryan1, K A Golosov1, I V Poluboyarinova1
1Sechenov First Moscow State Medical University (Sechenov University).
Terapevticheskii arkhiv
|February 20, 2026
概括
胰岛素的发展改变了1型糖尿病的管理. 早期的研究为现代便携式设备铺平了道路,改善了患者护理,并为人工胰腺铺平了道路.
科学领域:
- 内分泌学 在内分泌学.
- 医疗器械 医疗器械
- 糖尿病治疗方法 糖尿病治疗方法
背景情况:
- 20世纪对内分泌学至关重要,尤其是在治疗1型糖尿病方面.
- 胰岛素成为糖尿病管理的重大进步.
- 早期的胰岛素很大,以研究为导向,并与并发症有关.
研究的目的:
- 检查胰岛素技术的历史演变.
- 为了说明在开发早期胰岛素原型时所面临的挑战.
- 为突出现代胰岛素治疗和人工胰腺奠定了基础.
主要方法:
- 胰岛素发展的历史回顾,从最初到20世纪90年代初.
- 分析从研究设备向临床综合技术的过渡.
- 检查设备工程和安全方面的挑战和解决方案.
主要成果:
- 胰岛素从繁的研究工具演变为便携式,用户友好的设备.
- 安全性和实用性的显著改进促进了临床整合.
- 克服众多挑战标志着胰岛素开发的旅程.
结论:
- 胰岛素的历史发展对于推进1型糖尿病治疗至关重要.
- 胰岛素技术的发展显著改善了患者的治疗结果和日常管理.
- 这一进步为未来的创新奠定了基础,比如人工胰腺.
相关概念视频
01:31Hybridoma Technology
13.2K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
13.2K
01:30Production of Pharmaceuticals
99
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
99